BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Argos Therapeutics, Inc. (Formerly Merix Bioscience) 

4233 Technology Drive

Durham  North Carolina  27704  U.S.A.
Phone: 919-287-6300 Fax: 919-287-6301


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Duke University  Exclusive license to the RNA based vaccine technology.

Rockefeller University  Exclusive worldwide rights to technology developed at Rockefeller relating to generation of dendritic cells.

Baylor University  Clinical and preclinical research in Lupus.

Kirin Brewery Co., Ltd.  The companies will collaborate to develop and commercialize dendritic cell vaccines, initially in the areas of cancer and infectious diseases.

Erlangen University  Clinical and preclinical research in Melanoma.





 Company News
Argos Therapeutics, Inc. (ARGS) Receives 2014 Red Herring North America Top 100 Award 12/1/2014 4:16:37 PM
Argos Therapeutics, Inc. (ARGS) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/25/2014 11:14:13 AM
Argos Therapeutics, Inc. (ARGS) Reports Third Quarter 2014 Financial Results And Operational Highlights 11/14/2014 8:18:59 AM
Philippe Van Holle Joins Argos Therapeutics, Inc. (ARGS) Board Of Directors 11/13/2014 11:16:36 AM
Argos Therapeutics, Inc. (ARGS) To Present At The Stifel 2014 Healthcare Conference 11/12/2014 10:29:03 AM
Argos Therapeutics, Inc. (ARGS) To Hold Third Quarter 2014 Financial Results Conference Call On Thursday, November 13, 2014 11/6/2014 1:12:45 PM
Invetech And Argos Therapeutics, Inc. (ARGS) Announce Agreement To Support Global Production Of Fully Personalized Immunotherapies 11/5/2014 7:28:04 AM
Argos Therapeutics, Inc. (ARGS) Breaks Ground On State-Of-The-Art Biomanufacturing Facility In Research Triangle Park Area 10/22/2014 10:46:10 AM
Argos Therapeutics, Inc. (ARGS) To Hire 236 Staffers For $57 Million North Carolina Facility 10/3/2014 10:08:02 AM
Argos Therapeutics, Inc. (ARGS) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/1/2014 9:00:36 AM
12345678910...